55 related articles for article (PubMed ID: 9166539)
1. Why should primary care physicians know about breast cancer genetics?
Pinsky LE; Culver JB; Hull J; Levy-Lahad E; Daly M; Burke W
West J Med; 2001 Sep; 175(3):168-73. PubMed ID: 11527843
[No Abstract] [Full Text] [Related]
2. Editorial for familial cancer: cascade genetic testing.
Katapodi M; Ngeow J; Yie Y; Frey M
Fam Cancer; 2024 Jun; 23(2):109-110. PubMed ID: 38561561
[No Abstract] [Full Text] [Related]
3. Should All Individuals Be Screened for Genetic Predisposition to Cancer?
Wedderburn S; McVeigh TP
Genet Res (Camb); 2021; 2021():6611963. PubMed ID: 33762893
[No Abstract] [Full Text] [Related]
4. Practical considerations for reinterpretation of individual genetic variants.
Appelbaum PS; Berger SM; Brokamp E; Brown HS; Burke W; Clayton EW; Evans BJ; Hamid R; Marchant GE; Martin DM; O'Connor BC; Pagán JA; Parens E; Roberts JL; Rowe J; Schneider J; Siegel K; Veenstra DL; Chung WK
Genet Med; 2023 May; 25(5):100801. PubMed ID: 36748709
[TBL] [Abstract][Full Text] [Related]
5. Response to Peshkin, Isaacs, and Schwartz.
Caswell-Jin JL; Kurian AW
J Natl Cancer Inst; 2019 Aug; 111(8):874. PubMed ID: 30838406
[No Abstract] [Full Text] [Related]
6. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test.
Cho MK; Sankar P; Wolpe PR; Godmilow L
Am J Med Genet; 1999 Mar; 83(3):157-63. PubMed ID: 10096590
[TBL] [Abstract][Full Text] [Related]
7. "First do no harm" also applies to cancer susceptibility testing.
Burke W; Kahn MJ; Garber JE; Collins FS
Cancer J Sci Am; 1996; 2(5):250-2. PubMed ID: 9166540
[No Abstract] [Full Text] [Related]
8. 18. Genetics of breast cancer.
Irving M; Elmslie F; Berg J
Int J Clin Pract; 2002 Nov; 56(9):677-82. PubMed ID: 12469982
[TBL] [Abstract][Full Text] [Related]
9. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
10. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
James PA; Harris M; Lindeman GJ; Mitchell G
J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
[No Abstract] [Full Text] [Related]
11. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
Wolff TA; Wilson JE
Am Fam Physician; 2006 Nov; 74(10):1759-60. PubMed ID: 17137007
[No Abstract] [Full Text] [Related]
12. Genetic predisposition testing for breast cancer.
Schulman JD; Stern HJ
Cancer J Sci Am; 1996; 2(5):244-9. PubMed ID: 9166539
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
